A test designed to identify biomarkers associated with autism in infants and young children is now available to the public in most states. LinusBio, a New Jersey-based startup, on Thursday launched ...
Medical Device Network on MSN
MARAbio introduces MAR-Autism Test to detect maternal autoantibodies
MARAbio Systems has commercially introduced a new blood test for identifying maternal autoantibody related autism.
Scientists have announced a first-of-its-kind diagnostic test for autism spectrum disorder (ASD) that only requires a single strand of hair. LinusBio, based in New Jersey, launched its Clearstrand-ASD ...
MARAbio Systems (MARAbio), a precision immunology company dedicated to detecting, treating, and preventing Maternal Autoantibody Related Autism (MARA), has commercially launched the MAR-Autism Test, ...
A major new review has put hundreds of alternative autism treatments under the microscope—and most didn’t hold up. Scientists ...
A first-of-its-kind test claims to be able to help rule out autism in kids as young as 1 month using a single strand of hair, but not everyone is convinced that the technology is ready for prime time.
The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early ...
Please provide your email address to receive an email when new articles are posted on . ClearStrand-ASD was designed to help clinicians rule out autism in children aged 1 to 36 months. The technology ...
My second son, Jack*, was first diagnosed with autism at the age of 17. I had my own suspicions when he was at primary school; I sensed there was a difference between him and other children, but I ...
A test designed to identify biomarkers associated with autism just became available in most states. The test is meant to help physicians rule out autism in children who have higher likelihoods of it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results